[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Julià Blanco
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Julià Blanco aka Julian Blanco, PhD, leads the Cellular Virology and Immunology Group at the AIDS Research Institute IrsiCaixa, Barcelona, Spain.[1] Since 2010, Dr Blanco has explored immunological alterations in individuals suffering from CFS/ME.[2]
Education[edit | edit source]
- 1994, PhD in Biochemistry, University of Barcelona, Spain
EUROMENE[edit | edit source]
Dr. Blanco is a substitute member of the Socio-economics Working Group of ME/CFS across Europe on behalf of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[3]
Notable studies[edit | edit source]
- 2013, Screening NK-, B- and T-Cell phenotype and function in patients suffering from Chronic Fatigue Syndrome[4] (Full Text)
- 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE[5] (Full Text)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease[6] (Full Text)
Clinic location[edit | edit source]
The IrsiCaixa Research Institute studied AIDS, HIV, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).[7]
Talks and interviews[edit | edit source]
- 2014, Speaker at the 9th Invest in ME International ME Conference DVD available(no speech title given)
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ http://www.irsicaixa.es/en/juli%C3%A0-blanco
- ↑ http://www.euromene.eu/workinggroups/BiosketchJBLANCO.pdf
- ↑ http://www.cost.eu/COST_Actions/ca/CA15111?management
- ↑ Curriu, Marta; Carrillo, Jorge; Massanella, Marta; Rigau, Josepa; Alegre, José; Puig, Jordi; Garcia-Quintana, Ana M; Castro-Marrero, Jesús; Negredo, Eugènia; Clotet, Bonaventura; Cabrera, Cecilia; Blanco, Julià (2013), "Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome", Journal of Translational Medicine, 11 (68), doi:10.1186/1479-5876-11-68
- ↑ Scheibenbogen, Carmen; Freitag, Helma; Blanco, Julià; Capelli, Enrica; Lacerda, Eliana; Authier, Jerome; Meeus, Mira; Castro Marrero, Jesus; Nora-Krukle, Zaiga; Oltra, Elisa; Strand, Elin Bolle; Shikova, Evelina; Sekulic, Slobodan; Murovska, Modra (July 26, 2017). "The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE". Journal of Translational Medicine. 15 (1). doi:10.1186/s12967-017-1263-z. ISSN 1479-5876. PMC 5530475. PMID 28747192.
- ↑ Sotzny, Franziska; Blanco, Julià; Capelli, Enrica; Castro-Marrero, Jesús; Steiner, Sophie; Murovska, Modra; Scheibenbogen, Carmen (2018), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease", Autoimmunity Reviews, doi:10.1016/j.autrev.2018.01.009
- ↑ http://www.investinme.org/IIMEC9.shtml#presenters
